I suggest when they make promises that they keep them. Also I expect transparency and accountability. If that true-up lawsuit is still undecided, it would not bother me if they lost 2/3 of their share count based on their poor performance on scheduling the last three years, retail investors and Wall Street communication. Probably my last post allowed today so have at it.
Let’s just say the product will be successful for all tumors but she has caused a great many investors grief and loss in their expected returns on their original investment which could have been salvaged if she wasn’t always looking out for #1 and considered shareholders.
Market Data 
Markets 
AI
